Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study
Nicoletta Colombo, Angiolo Gadducci, Fabio Landoni, Domenica Lorusso, Roberto Sabbatini, Grazia Artioli, Rossana Berardi, Rita Ceccherini, Sabrina Chiara Cecere, Gennaro Cormio, Carmine De Angelis, Francesco Legge, Andrea Alberto Lissoni, Serafina Mammoliti, Giorgia Mangili, Emanuele Naglieri, Maria Cristina Petrella, Giuseppina Rosaria Rita Ricciardi, Graziana Ronzino, Vanda Salutari, Daniela Sambataro, Antonella Savarese, Giuseppa Scandurra, Giulia Tasca, Federica Tomao, Giorgio Valabrega, Laura Zavallone, Sandro Pignata
Topics & Concepts
MedicineBevacizumabOlaparibMaintenance therapyOncologyInternal medicineOvarian carcinomaOvarian cancerTargeted therapyDelphi methodChemotherapyIntensive care medicineCancerPolymeraseBiochemistryChemistryStatisticsPoly ADP ribose polymeraseGeneMathematicsPARP inhibition in cancer therapyOvarian cancer diagnosis and treatmentReproductive Biology and Fertility